S-8

As filed with the Securities and Exchange Commission on May 20, 2004 Registration No. 333-_______

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM S-8

REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933

GLOBAL MED TECHNOLOGIES, INC.
(Exact name of Registrant as specified in its charter)

Colorado
(State or other jurisdiction of
 incorporation or organization) 84-1116894
(I.R.S. Employer
I.D. Number)

12600 West Colfax, Suite C-420, Lakewood, Colorado 80215
(Address of Principal Executive Offices, including Zip Code)

GLOBAL MED TECHNOLOGIES, INC. 2003 STOCK OPTION PLAN
(Full title of the plan)

Michael I. Ruxin, M.D.
Global Med Technologies, Inc.
12600 West Colfax, Suite C-420
Lakewood, CO 80215
(303) 238-2000
(Name, address and telephone number of agent for service)

CALCULATION OF REGISTRATION FEE

Title of each class of securities to be registered	Amount to be registered(1)	Proposed maximum offering price per share(2)	Proposed maximum aggregate offering price (2)	Amount of registration fee (2)
Common Stock	5,000,000 shares (3)	$0.58	$2,900,000	$368

(1) There are also registered hereunder such indeterminate number of additional shares of the Registrant’s $.01 par value common stock (“Common Stock”) as may become subject to the Registrant's 2003 Stock Option Plan as a result of the anti-dilution provisions thereof.

(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c), based on the average of the bid and asked price of the Registrant’s Common Stock as of May 18, 2004.

(3) This Registration Statement registers 5,000,000 shares of the Registrant’s Common Stock reserved for issuance under the 2003 Stock Option Plan.

(The Exhibit Index is located on Page 8)

PART I

INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1.   Plan Information.

     The required Plan Information is included in documents being maintained and delivered by the Registrant as required by Rule 428 of the Securities Act of 1933, as amended (the “Act”).

Item 2.   Registrant Information and Employee Plan Annual Information.

     The Registrant will provide to participants a written statement advising them of the availability, without charge, upon written or oral request, of documents incorporated by reference in Item 3 of Part II hereof, and stating that these documents are incorporated by reference in the Section 10(a) prospectus. The statement also will indicate the availability without charge, upon written or oral request of other documents required to be delivered pursuant to Rule 428(b) under the Act. The statement will include the address (giving title and department) and telephone number to which the request is to be directed.

PART II

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.   Incorporation of Documents by Reference.

     The following documents filed with the Securities and Exchange Commission (the “Commission”) by the Registrant are incorporated by reference into this Registration Statement:

(a) The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003, as filed on April 14, 2004;

(b) All other reports filed by the Registrant with the Commission pursuant to Section 13 of the Securities Exchange Act of 1934 Act, as amended (the “Exchange Act”), since the end of the fiscal year covered by the Annual Report referred to in (a); and

(c) The description of the Common Stock contained in the Registrant’s Form 8-A Registration Statement under the Exchange Act, as filed on January 31, 1997.

     All documents filed by the Registrant with the Commission pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall, except to the extent otherwise provided by Regulation S-K or any other rule promulgated by the Commission, be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents.

2

Item 4.   Description of Securities.

     No description of the class of securities to be offered is required under this Item because the class of securities to be offered is registered under Section 12 of the Exchange Act.

Item 5.   Interests of Named Experts and Counsel.

     None.

Item 6.   Indemnification of Directors and Officers.

     A. The Colorado Business Corporation Act (the “Act”) provides that a corporation shall indemnify an officer or director, and may indemnify an employee, fiduciary or agent, of the Company who was wholly successful, on the merits or otherwise, in the defense of any proceeding to which such person was a party because the person is or was an officer, director, employee, fiduciary or agent against reasonable expenses incurred by him or her in connection with the proceeding. The Act allows indemnification of directors, officers, employees, fiduciaries and agents of the corporation for reasonable expenses incurred in connection with any proceeding in which an individual is made a party because he was a director, officer, employee, fiduciary or agent of the corporation if:

(a) The person conducted himself or herself in good faith; and

(b) The person reasonably believed:

(i) In the case of conduct in an official capacity with the corporation, that his or her conduct was in the corporation’s best interests; and

(ii) In all other cases, that his or her conduct was at least not opposed to the corporation’s best interests; and

(c) In the case of any criminal proceeding, the person had no reasonable cause to believe his or her conduct was unlawful.

     A person must be found to be entitled to indemnification under this statutory standard by procedures designed to assure that disinterested members of the board of directors have approved indemnification or that, absent the ability to obtain sufficient numbers of disinterested directors, independent counsel or shareholders have approved the indemnification based on a finding that the person has met the standard.

3

     The Company’s Articles of Incorporation, as amended, provide that the Company shall indemnify, to the fullest extent permitted by applicable law, any person, and the estate and personal representative of any such person, against all liability and expense (including attorneys’ fees) incurred by reason of the fact that he is or was a director or officer of the Company or, while serving at the request of the Company as a director, officer, partner, trustee, employee, fiduciary, or agent of, or in any similar managerial or fiduciary position of, another domestic or foreign corporation or other individual or entity or of an employee benefit plan. The Company also shall indemnify any person who is serving or has served the Company as director, officer, employee, fiduciary, or agent, and that person’s estate and personal representative, to the extent and in the manner provided in any bylaw, resolution of the shareholders or directors, contract, or otherwise, so long as such provision is legally permissible. The Company’s Bylaws, as amended, also provide that the Company shall indemnify its officers, directors and employees to the fullest extent permitted by law.

     The Company’s Articles of Incorporation, as amended, provide that a director of the Company shall not be personally liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the Company or to its shareholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for acts specified under Section 7-108-403 of the Act or any amended or successor provision thereof, or (iv) for any transaction from which the director derived an improper personal benefit. If the Act is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Act, as so amended.

     The foregoing is limited and qualified in its entirety by reference to the Act and the Registrant’s Articles of Incorporation, as amended and Bylaws, as amended.

Item 7.   Exemption from Registration Claimed.

     Not applicable.

Item 8.   Exhibits.

     The following is a complete list of exhibits filed as a part of this Registration Statement, which Exhibits are incorporated herein.

4.3 Specimen Copy of Stock Certificate for Common Stock. (Incorporated by reference from the like numbered exhibit filed with the Registrant’s Registration Statement on Form SB-2, Registration No. 333-11723)

5.1 Opinion of Tenenbaum & Kreye LLP

10.68 Global Med Technologies Inc. 2003 Stock Option Plan

23.1 Consent of Ehrhardt Keefe Steiner & Hottman PC

23.2 Consent of Tenenbaum & Kreye LLP - See Exhibit 5.1.

4

Item 9.    Undertakings

     The registrant hereby undertakes:

     (a)(1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

     (i) To include any prospectus required by Section 10(a)(3) of the Securities Act of 1933.

     (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement.;

     (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

     Provided, however, that paragraphs (i) and (ii) do not apply if the registration statement is on Form S-3 or Form S-8 and the information required to be included in the post-effective amendment by those paragraphs is contained in periodic reports filed by the Registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement.

     (2) That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

     (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

     (b)  The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act of 1933, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934 (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

5

     (c)  Insofar as indemnification for liabilities arising under the Act, as amended, may be permitted to officers and directors of the Company pursuant to the above-mentioned By-Laws and statute, the Company has been advised that, in the opinion of the Securities and Exchange Commission, such indemnification is against public policy as expressed in the Act, and is, therefore, unenforceable. In the event that a claim for such indemnification (except insofar as it provides for payment by the Company of expenses incurred or paid by a director or officer in the successful defense of any action, suit or proceeding) is asserted against the Company by a director or officer and the Commission is still of the same opinion, the Company will, unless the matter has, in the opinion of its counsel, been adjudicated by precedent deemed by it to be controlling, submit to a court of appropriate jurisdiction the question of whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City and County of Denver, State of Colorado on May 20, 2004.

GLOBAL MED TECHNOLOGIES, INC.
Registrant


By: /s/ Michael I. Ruxin,                  
          Michael I. Ruxin, M.D.
          Chairman of the Board of Directors and
          Chief Executive Officer

     Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date

 /s/ Michael I. Ruxin              
Michael I. Ruxin Chairman of the Board
and Chief Executive Officer
and Director and Acting
Principal Accounting and
Financial Officer May 20, 2004

 /s/ Thomas F. Marcinek          
Thomas F. Marcinek President and Chief
Operating Officer May 14, 2004

6

Signature Title Date

 /s/ Gary L. Cook                   
Gary L. Cook Director, Acting Principal
Financial and Accounting
Officer and Treasurer through
February 25, 2004 May 17, 2004

 /s/ Gerald F. Willman, Jr.        
Gerald F. Willman, Jr. Director and Wyndgate
Vice President Sales and
Marketing (Wyndgate
Technologies) May 18, 2004

 /s/ Fai H. Chan                      
Fai H. Chan Director May 20, 2004

 /s/ Robert H. Trapp               
Robert H. Trapp Director May 19, 2004

 /s/ Kwok Jen Fong                 
Kwok Jen Fong Director May 18, 2004

 /s/ Tony T. W. Chan               
Tony T. W. Chan Director May 20, 2004

 /s/ David T. Chen                   
David T. Chen Director May 14, 2004

7

EXHIBIT INDEX

The following is a complete list of exhibits filed as a part of this Registration Statement, which Exhibits are incorporated herein.

Exhibit No. Description

4.3 Specimen Copy of Stock Certificate for Common Stock. (Incorporated by reference from the like numbered exhibit filed with the Registrant’s Registration Statement on Form SB-2, Registration No. 333-11723)

5.1 Opinion of Tenenbaum & Kreye LLP

10.68 Global Med Technologies Inc. 2003 Stock Option Plan

23.1 Consent of Ehrhardt Keefe Steiner & Hottman PC

23.2 Consent of Tenenbaum & Kreye LLP - See Exhibit 5.1.

8

EX-5

EXHIBIT 5.1

TENENBAUM & KREYE LLP

ATTORNEYS AT LAW

PLAZA TOWER ONE, SUITE 2025
6400 S. FIDDLER'S GREEN CIRCLE
ENGLEWOOD, COLORADO 80111
PH: (720) 529-0900
FX: (720) 529-9003

May 20, 2004

Board of Directors
Global Med Technologies, Inc.
12600 West Colfax, Suite C-420
Lakewood, Colorado 80215

Re: Global Med Technologies, Inc. - Registration Statement on Form S-8

Gentlemen:

     We have acted as counsel to Global Med Technologies, Inc., a Colorado corporation (the “Company”), in connection with the preparation and filing with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”), the Company’s Registration Statement on Form S-8 (the “Registration Statement”). The Registration Statement relates to the registration under the Securities Act of an aggregate of 5,000,000 shares (the “Shares”) of common stock, $.01 par value (“Common Stock”), reserved for issuance under the Company’s 2003 Stock Option Plan (the “2003 Plan”).

     This opinion is governed by, and shall be interpreted in accordance with the Legal Opinion Accord (the “Accord”) of the American Bar Association Section of Business Law (1991). As a consequence, it is subject to a number of qualifications, exceptions, definitions, limitations on coverage and other limitations, all as more particularly described in the Accord, in addition to the qualifications, exceptions and limitations specifically set forth herein and this opinion should be read in conjunction therewith. In the event of any inconsistency between the qualification, exception and limitations of the Accord and those specifically set forth herein, the more restrictive qualifications, exceptions and limitations shall control.

     In rendering this opinion, we have reviewed, without independent verification: (i) the Registration Statement and exhibits thereto; (ii) a copy of the Company’s articles of incorporation and bylaws, each as amended to date; (iii) certain records of the Company’s corporate proceedings as reflected in its minute book; and, (iv) such statutes, records and other documents as we have deemed relevant. We also have assumed without investigation: (i) the genuineness of all signatures; (ii) the authenticity of documents submitted to us as originals; (iii) the authenticity and conformity to original documents of documents submitted to us as copies of original documents, and, (iv) that the foregoing documents, in the forms thereof submitted for our review, have not been altered, amended or repealed in any respect material to our opinion as stated herein. We have not reviewed any documents other than the documents listed above for purposes of rendering our opinion as expressed herein, and we assume that there exists no provision of any such other document that bears upon or is inconsistent with our opinion as expressed herein. We have conducted no independent factual investigation of our own but rather have relied solely upon the foregoing documents, the statements, and information set forth therein and the additional matters recited or assumed herein, all of which we assume to be true, complete and accurate in all material respects.

     Based upon and in reliance upon the foregoing, and subject to the qualifications and limitations herein set forth, we are of the opinion that when and if: (i) the Registration Statement has become effective; (ii) the Company’s Board of Directors duly approve the issuance of the Shares; (iii) the Shares have been issued and sold for the consideration contemplated by and in accordance with the provisions and requirements of the 2003 Plan and the Registration Statement (provided that at least par value is paid for the Shares); and (iv) the applicable provisions and requirements of the Securities Act and all such other applicable laws and governing documents, have been complied with, the Shares of Common Stock reserved for issuance under the Company’s 2003 Plan will be legally issued, fully paid and non-assessable, subject to limitations imposed by bankruptcy, insolvency, reorganization, moratorium or similar laws and related court decisions of general applicability relating to or affecting creditors’ rights generally. This opinion does not cover any matters related to any re-offer or re-sale of the Shares, once issued pursuant to the 2003 Plan as described in the Registration Statement.

     Regardless of the jurisdictions in which members of this firm are licensed to practice, the foregoing opinion is limited in all respects to the present corporate laws of the State of Colorado (“Applicable Law”), and does not extend to the securities or Blue-Sky laws of Colorado, conflict of law rules, the federal securities and other laws of the United States, the laws of any other state or jurisdiction, or the rules and regulations of stock exchanges or any other regulatory body. Applicable Law includes only the corporate laws of the State of Colorado that a lawyer exercising customary professional diligence would reasonably recognize as being directly applicable to the issuance and sale of the Shares pursuant to the 2003 Plan and does not include laws and legal issues of the type described in Section 19 of the Accord. This opinion is based upon our knowledge of the law and facts as of this date. We assume no duty or obligation to communicate to you with respect to any matter that comes to our attention hereafter or to revise or supplement this opinion letter should the Applicable Law change after the date hereof by legislative action, judicial decision or otherwise.

     We hereby consent to the use of this opinion as Exhibit 5.1 to the Registration Statement. However, in giving such consent we do not (i) consider that we are “experts” within the meaning of such term as used in the Securities Act, or the rules and regulations of the Commission thereunder, with respect to the registration statement, or with respect to this opinion, as an exhibit or otherwise, or (ii) admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission thereunder. This opinion, any copies hereof or any extract herefrom may not be published, relied upon by, delivered to, or quoted in whole or in part to any governmental agency or other person without our prior written consent. This opinion is provided to you as a legal opinion only, and not as a guaranty or warranty of the matters discussed herein. Our opinion is limited to the matters expressly stated herein, and no other opinions may be implied or inferred.

Very truly yours,

/s/ Tenenbaum & Kreye LLP

EX-10

EXHIBIT 10.68

GLOBAL MED TECHNOLOGIES, INC.
2003 STOCK OPTION PLAN

     Purposes of and Benefits Under the Plan. This 2003 Stock Option Plan (the “Plan”) is intended to encourage stock ownership by employees, officers and directors (whether or not they are employees) of and consultants to GLOBAL MED TECHNOLOGIES, INC., its divisions, Subsidiary corporations and Parent corporations (the “Corporation”), so that they may acquire or increase their proprietary interest in the Corporation, to (i) induce qualified persons to become employees, officers or directors of or consultants to the Corporation; (ii) reward employees, directors, and consultants for past services to the Corporation; and/or (iii) encourage such persons to remain in the employ of or associated with the Corporation and to put forth maximum efforts for the success of the business of the Corporation.

     It is intended that options granted by the Committee pursuant to this Plan shall constitute “non-qualified stock options” (“Non-qualified Stock Options”).

     Any options granted and outstanding at the time this Plan is adopted by the Board may be governed by the terms of and be deemed issued under this Plan at the discretion of the Board. If any provision of this Plan materially conflicts with a provision of such an outstanding stock option, the provisions of such stock option shall govern.

     1.   Definitions. As used in this Plan, the following words and phrases shall have the meanings indicated:

          (a)   “Board” means the Board of Directors of the Corporation.

          (b)   “Code” means Internal Revenue Code of 1986, as amended from time to time.

          (c)   “Committee” means the Compensation Committee appointed by the Board, and/or the Board.

          (d)   “Common Stock” means the Corporation’s $.01 par value common stock.

          (e)   “Disability” means a Recipient’s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than 12 months.

          (f)   “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time.

          (g)   “Fair Market Value” per share as of a particular date means the last sale price of the Corporation’s Common Stock as reported on a national securities exchange or on the NASDAQ National Market System or, if the quotation for the last sale reported is not available for the Corporation’s Common Stock, the average of the closing bid and asked prices of the Corporation’s Common Stock as reported by NASDAQ or on the electronic bulletin board or, if none, the National Quotation Bureau, Inc.‘s “Pink Sheets” or, if such quotations are unavailable, the value determined by the Committee in accordance with its discretion in making a bona fide, good faith determination of fair market value. Fair Market Value shall be determined without regard to any restriction other than a restriction which, by its terms, never will lapse.

          (h)   “Option” means a Non-qualified Stock Option.

          (i)   “Option Price” means the purchase price of the shares of Common Stock covered by an Option determined in accordance with Section 6 (b) hereunder.

          (j)   “Parent” means any corporation which is a “parent corporation” as defined in Section 424(e) of the Code, with respect to the Corporation.

          (k)   “Plan” means this 2003 Stock Option Plan.

          (l)   “Recipient” means any person granted an Option hereunder whether such grant occurred before or after this Plan was adopted by the Board.

          (m)   “Securities Act” means the Securities Act of 1933, as amended from time to time.

          (n)   “Subsidiary” means any corporation which is a “subsidiary corporation” as defined in Section 424(f) of the Code, with respect to the Corporation.

2

          2.    Administration.

          (a)   The Plan shall be administered by the Committee. The Committee shall have the authority in its discretion, subject to and not inconsistent with the express provisions of the Plan, to administer the Plan and to exercise all the powers and authorities either specifically conferred under the Plan or necessary or advisable in the administration of the Plan, including the authority to grant Options; to determine the vesting schedules and other restrictions, if any, relating to Options; to determine the Option Price; to determine the persons to whom, and the time or times at which, Options shall be granted; to determine the number of shares to be covered by each Option; to determine Fair Market Value per share; to interpret the Plan; to prescribe, amend and rescind rules and regulations relating to the Plan; to determine the terms and provisions of the Stock Option Grants (which need not be identical) entered into in connection with Options granted under the Plan; and to make all other determinations deemed necessary or advisable for the administration of the Plan. The Committee may delegate to one or more of its members or to one or more agents such administrative duties as it may deem advisable, and the Committee or any person to whom it has delegated duties as aforesaid may employ one or more persons to render advice with respect to any responsibility the Committee or such person may have under the Plan.

          (b)   Options granted under the Plan shall be evidenced by duly adopted resolutions of the Committee included in the minutes of the meeting at which they are adopted or in a unanimous written consent.

          (c)   With respect to persons subject to Section 16 of the Exchange Act, transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 or any successor regulation under the Exchange Act. To the extent any provision of this Plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by law and deemed advisable by the Committee. Any Option granted hereunder which would subject or subjects the Recipient to liability under Section 16(b) of the Exchange Act is void ab initio as if it had never been granted.

          (d)   No member of the Committee or the Board shall be liable for any action taken or determination made in good faith with respect to the Plan or any Option granted hereunder.

     3.    Eligibility.

          (a)   Subject to certain limitations hereinafter set forth, Options may be granted to employees, officers and directors (whether or not they are employees) of and consultants to the Corporation. In addition, Options granted to employees, officers, directors, and consultants, outstanding at the time this Plan is adopted by the Board, may be deemed issued under this Plan at the discretion of the Board. In determining the persons to whom Options shall be granted and the number of shares to be covered by each Option, the Committee may take into account the duties of the respective persons, their present and potential contributions to the success of the Corporation and such other factors as the Committee shall deem relevant to accomplish the purposes of the Plan.

          (b)   A Recipient shall be eligible to receive more than one grant of an Option during the term of the Plan, on the terms and subject to the restrictions herein set forth.

3

     4.   Stock Reserved.

          (a)   The stock subject to Options hereunder shall be shares of Common Stock. Such shares, in whole or in part, may be authorized but unissued shares or shares that shall have been or that may be reacquired by the Corporation. The aggregate number of shares of Common Stock as to which Options may be granted from time to time under the Plan (the “Available Shares”) shall not exceed 5,000,000 shares. The number of Available Shares shall be subject to adjustment as provided in Section 6.

          (b)   If any outstanding Option under the Plan for any reason expires or is terminated without having been exercised in full, the shares of Common Stock allocable to the unexercised portion of such Option shall become available for subsequent grants of Options under the Plan, unless the Plan shall have been terminated.

     5.    Stock Options.

     Options granted pursuant to this Plan are intended to constitute Non-qualified Stock Options and shall be subject to the general terms and conditions specified in Section 6, and as determined by resolutions of the Committee.

     6.    Terms and Conditions of Options. Each Option granted pursuant to the Plan shall be evidenced by a written Stock Option Grant between the Corporation and the Recipient, which Stock Option Grant may be in the form of Exhibit A hereto or in any other form as approved by the Committee in its discretion, and which shall comply with and be subject to the following terms and conditions:

          (a)   Number of Shares. Each Stock Option Grant shall state the number of shares of Common Stock covered by the Option.

          (b)   Option Price. Each Stock Option Grant shall state the Option Price, which shall be determined by the Committee and shall be subject to adjustment as provided in this Section 6.

          (c)   Term of Option. Each Stock Option Grant shall state the period during and times at which the Option shall be exercisable; provided, however:

               (1)   The date on which the Committee adopts a resolution expressly granting an Option shall be considered the day on which such Option is granted, unless a future date is specified in the resolution; provided, however, the Recipient shall have no rights under the grant until the Recipient has executed a Stock Option Grant with respect to such Option.

               (2)   The exercise period shall not exceed ten years from the date of grant of the Option.

               (3)   The Committee shall have the authority to accelerate or extend the exercisability of any outstanding Option at such time and under such circumstances as it, in its sole discretion, deems appropriate. No exercise period may be extended to increase the term of the Option beyond ten years from the date of the grant.

4

               (4)   The exercise period shall be subject to earlier termination as provided in This Section 6 and, furthermore, shall be terminated upon surrender of the Option by the holder thereof if such surrender has been authorized in advance by the Committee.

          (d)   Method of Exercise and Medium and Time of Payment.

               (1)   An Option may be exercised as to any or all whole shares of Common Stock as to which it then is exercisable.

               (2)   Each exercise of an Option granted hereunder, whether in whole or in part, shall be by written notice to the Corporation c/o Michael I. Ruxin, M.D., Chairman of the Board of Directors and CEO, at 12600 West Colfax, Suite C-420, Lakewood, Colorado 80215, designating the number of shares as to which the Option is being exercised, and shall be accompanied by payment in full of the Option Price for the number of shares so designated, together with any written statements required by any applicable securities laws.

               (3)   The Option Price shall be paid in cash, in shares of Common Stock having a Fair Market Value equal to such Option Price or in property or in a combination of cash, shares and property and, subject to approval of the Committee, may be effected in whole or in part (A) with monies received from the Corporation at the time of exercise as a compensatory cash payment, or (B) with monies borrowed from the Corporation pursuant to repayment terms and conditions as shall be determined from time to time by the Committee, in its discretion, separately with respect to each exercise of an Option and each Recipient; provided, however, that each such method and time for payment and each such borrowing and the terms and conditions of repayment shall be permitted by and be in compliance with applicable law.

               (4)   The Committee shall have the sole and absolute discretion to determine whether or not property other than cash or Common Stock may be used to purchase the shares of Common Stock hereunder and, if so, to determine the value of the property received.

               (5)   Applicable withholding taxes shall be paid in the manner specified by Section 7 hereof.

          (e)   Termination.

               (1)   All Stock Options granted under the Plan shall terminate, in accordance with the terms set forth in the Stock Option Grant.

               (2)   Nothing in the Plan or in any Option granted hereunder shall confer upon an individual any right to continue in the employ of or other relationship with the Corporation or interfere in any way with the right of the Corporation to terminate such employment or other relationship between the individual and the Corporation.

5

          (f)   Death, Disability or Retirement of Recipient. If a Recipient shall die while an employee, officer or director of or a consultant to the Corporation, or if the Recipient’s employment, officer or director status or consulting relationship, shall terminate by reason of Disability or retirement, all Options theretofore granted to such Recipient, if otherwise exercisable, and unless earlier terminated in accordance with their terms, may be exercised by the Recipient or by the Recipient’s estate or by a person who acquired the right to exercise such Options by bequest or inheritance or otherwise by reason of the death or Disability of the Recipient, at any time within one year after the date of death, Disability or retirement of the Recipient.

          (g)   Transferability Restriction.

               (1)   Options granted under the Plan shall not be transferable other than by will or by the laws of descent and distribution or pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement Income Security Act of 1974, or the rules there under. Options may be exercised, during the lifetime of the Recipient, only by the Recipient and thereafter only by his legal representative.

               (2)   Any attempted sale, pledge, assignment, hypothecation or other transfer of an Option contrary to the provisions hereof and the levy of any execution, attachment or similar process upon an Option shall be null and void and without force or effect and shall result in a termination of the Option.

               (3)(A)   As a condition to the transfer of any shares of Common Stock issued upon exercise of an Option granted under this Plan, the Corporation may require an opinion of counsel, satisfactory to the Corporation, to the effect that such transfer will not be in violation of the Securities Act or any other applicable securities laws or that such transfer has been registered under federal and all applicable state securities laws. (B) Further, the Corporation shall be authorized to refrain from delivering or transferring shares of Common Stock issued under this Plan until the Committee determines that such delivery or transfer will not violate applicable securities laws and the Recipient has tendered to the Corporation any federal, state or local tax owed by the Recipient as a result of exercising the Option or disposing of any Common Stock when the Corporation has a legal liability to satisfy such tax. (C) The Corporation shall not be liable for damages due to delay in the delivery or issuance of any stock certificate for any reason whatsoever, including, but not limited to, a delay caused by listing requirements of any securities exchange or the National Association of Securities Dealers, or any registration requirements under the Securities Act, the Exchange Act, or under any other state or federal law, rule or regulation. (D) The Corporation is under no obligation to take any action or incur any expense in order to register or qualify the delivery or transfer of shares of Common Stock under applicable securities laws or to perfect any exemption from such registration or qualification. (E) Furthermore, the Corporation will not be liable to any Recipient for failure to deliver or transfer shares of Common Stock if such failure is based upon the provisions of this paragraph.

6

          (h)   Effect of Certain Changes.

               (1)   If there is any change in the number of shares of Common Stock through the declaration of stock dividends, or through a recapitalization resulting in stock splits, or combinations or exchanges of such shares, the number of shares of Common Stock available for Options and the number of such shares covered by outstanding Options, and the exercise price per share of the outstanding Options, shall be proportionately adjusted by the Committee to reflect any increase or decrease in the number of issued shares of Common Stock; provided, however, that any fractional shares resulting from such adjustment shall be eliminated.

               (2)   In the event of the proposed dissolution or liquidation of the Corporation, or any corporate separation or division, including, but not limited to, split-up, split-off or spin-off, merger or consolidation of the Corporation with another corporation, or any sale or transfer by the Corporation of all or substantially all its assets or any tender offer or exchange offer for or the acquisition, directly or indirectly, by any person or group for more than 50% of the then outstanding voting securities of the Corporation, the Committee may provide that the holder of each Option then exercisable shall have the right to exercise such Option (at its then current Option Price) solely for the kind and amount of shares of stock and other securities, property, cash or any combination thereof receivable upon such dissolution, liquidation, corporate separation or division, merger or consolidation, sale or transfer of assets or tender offer or exchange offer, by a holder of the number of shares of Common Stock for which such Option might have been exercised immediately prior to such dissolution, liquidation, or corporate separation or division, merger or consolidation, sale or transfer of assets or tender offer or exchange offer; or in the alternative the Committee may provide that each Option granted under the Plan shall terminate as of a date fixed by the Committee; provided, however, that not less than 30 days’ written notice of the date so fixed shall be given to each Recipient, who shall have the right, during the period of 30 days preceding such termination, to exercise the Option to the extent then exercisable.

               (3)   Paragraph (2) of this Section shall not apply to a merger or consolidation in which the Corporation is the surviving corporation and shares of Common Stock are not converted into or exchanged for stock, securities of any other corporation, cash or any other thing of value. Notwithstanding the preceding sentence, in case of any consolidation or merger of another corporation into the Corporation in which the Corporation is the surviving corporation and in which there is a reclassification or change (including a change which results in the right to receive cash or other property) of the shares of Common Stock (other than a change in par value, or from par value to no par value, or as a result of a subdivision or combination, but including any change in such shares into two or more classes or series of shares), the Committee may provide that the holder of each Option then exercisable shall have the right to exercise such Option solely for the kind and amount of shares of stock and other securities (including those of any new direct or indirect Parent of the Corporation), property, cash or any combination thereof receivable upon such reclassification, change, consolidation or merger by the holder of the number of shares of Common Stock for which such Option might have been exercised.

7

               (4)   If there is a change in the Common Stock of the Corporation as presently constituted, which is limited to a change of all of its authorized shares with par value into the same number of shares with a different par value or without par value, the shares resulting from any such change shall be deemed to be the Common Stock within the meaning of the Plan.

               (5)   To the extent that the foregoing adjustments relate to stock or securities of the Corporation, such adjustments shall be made by the Committee, whose determination in that respect shall be final, binding and conclusive.

               (6)   Except as expressly provided in this Section, the Recipient shall have no rights by reason of any subdivision or consolidation of shares of stock of any class or the payment of any stock dividend or any other increase or decrease in the number of shares of stock of any class or by reason of any dissolution, liquidation, merger, or consolidation or split-up, split-off or spin-off of assets or stock of another corporation; and any issue by the Corporation of shares of stock of any class, or securities convertible into shares of stock of any class, shall not affect, and no adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to the Option. The grant of an Option under the Plan shall not affect in any way the right or power of the Corporation to make adjustments, reclassifications, reorganizations or changes of its capital or business structures or to merge or to consolidate or to dissolve, liquidate or sell, or transfer all or part of its business or assets.

          (i)   Rights as Shareholder — Non-Distributive Intent.

               (1)   Neither a person to whom an Option is granted, nor such person's legal representative, heir, legatee or distributee, shall be deemed to be the holder of, or to have any rights of a holder with respect to, any shares of Common Stock subject to such Option until after the Option is exercised and the shares are issued to the person exercising such Option.

               (2)   Upon exercise of an Option at a time when there is no registration statement in effect under the Securities Act relating to the shares issuable upon exercise, shares may be issued to the Recipient only if the Recipient represents and warrants in writing to the Corporation that the shares purchased are being acquired for investment and not with a view to the distribution thereof and provides the Corporation with sufficient information to establish an exemption from the registration requirements of the Securities Act. A form of subscription agreement is attached hereto as Exhibit B.

               (3)   No shares shall be issued upon the exercise of an Option unless and until there shall have been compliance with any then applicable requirements of the Securities and Exchange Commission, or any other regulatory agencies having jurisdiction over the Corporation.

8

               (4)   No adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other property) or distribution or other rights for which the record date is prior to the date such stock certificate is issued, except as provided in This Section 6.

          (j)   Other Provisions. Stock Option Grants evidencing Options granted under the Plan shall contain such other provisions, including, without limitation, the imposition of restrictions upon the exercise of an Option, as the Committee shall deem advisable.

     7.    Agreement by Recipient Regarding Withholding Taxes. Each Recipient agrees that the Corporation, to the extent permitted or required by law, may deduct a sufficient number of shares due to the Recipient upon exercise of the Option to allow the Corporation to pay federal, state and local taxes of any kind required by law to be withheld upon the exercise of such Option from any payment of any kind otherwise due to the Recipient. The Corporation shall not be obligated to advise any Recipient of the existence of any tax or the amount which the Corporation may be required to withhold.

     8.   Term of Plan. Options may be granted under this Plan from time to time until June 5, 2013, which is ten years from the Plan was adopted by the Board of Directors of the Corporation.

     9.    Amendment and Termination of the Plan. The Committee at any time and from time to time may suspend, terminate, modify or amend the Plan. Except as provided in Section 6, no suspension, termination, modification or amendment of the Plan may adversely affect any Option previously granted, unless the written consent of the Recipient is obtained.

     10.    Assumption. Subject to Section 6, the terms and conditions of any outstanding Options granted under this Plan shall be assumed by, be binding upon and shall inure to the benefit of any successor corporation to the Corporation and continue to be governed by, to the extent applicable, the terms and conditions of this Plan. Such successor corporation may, but shall not be obligated to, assume this Plan.

     11.    Termination of Right of Action. Every right of action arising out of or in connection with the Plan by or on behalf of the Corporation, or by any shareholder of the Corporation against any past, present or future member of the Committee and/or Board, or against any agent or employee, or by an agent or employee (past, present or future) against the Corporation, irrespective of the place where an action may be brought and of the place of residence of any such shareholder, director, agent or employee, will cease and be barred by the expiration of three years from the date of the act or omission in respect of which such right of action is alleged to have risen or such shorter period as may be provided by law.

     12.    Tax Litigation. The Corporation shall have the right, but not the obligation, to contest, at its expense, any tax ruling or decision, administrative or judicial, on any issue which is related to the Plan and which the Committee believes to be important to holders of Options granted under the Plan and to conduct any such contest or any litigation arising there from to a final decision.

9

     13.    Financial Statement. The Corporation may, but is not required to, provide holders of Options with a financial statement of the Corporation on an annual basis.

     14.    Adoption. This Plan was approved by the Board of Directors of the Corporation on June 5, 2003.

GLOBAL MED TECHNOLOGIES, INC.


By______________________________
    Michael I. Ruxin, M.D., Chairman of the
    Board of Directors and Chief Executive
    Officer

10

Exhibit A

FORM OF
NON-QUALIFIED STOCK OPTION GRANT

     STOCK OPTION GRANT effective as of this ____ day of _____________, ______, between GLOBAL MED TECHNOLOGIES, INC., a Colorado corporation (the “Corporation”), and ___________________ (the “Recipient”).

     In accordance with its 2003 Stock Option Plan (the “Plan”), a copy of which has been provided to the Recipient and is incorporated herein by reference, the Corporation desires, in connection with the services of the Recipient, to provide the Recipient with an opportunity to acquire $0.01 par value common stock (“Common Stock”) of the Corporation on favorable terms and thereby increase the Recipient’s proprietary interest in the Corporation and as incentive to put forth maximum efforts for the success of the business of the Corporation. All capitalized terms not otherwise defined herein shall be as defined in the Plan.

     NOW, THEREFORE, in consideration of the premises and mutual covenants herein set forth and other good and valuable consideration, the Corporation and the Recipient agree as follows:

     1.    Confirmation of Grant of Option. Pursuant to a determination of the Committee (as defined in the Plan) made on ____________, _____ (the “Date of Grant”), the Corporation subject to the terms of the Plan and of this Stock Option Grant, confirms that the Recipient irrevocably has been granted on the Date of Grant, as a matter of separate inducement and agreement, and in addition to and not in lieu of salary or other compensation for services, a Non-qualified Stock Option pursuant to Section 6 of the Plan (the “Option”) to purchase an aggregate of _________ shares of Common Stock on the terms and conditions herein set forth, subject to adjustment as provided in Paragraph 9 hereof.

     2.    Option Price. The Option Price per share of Common Stock covered by the Option will be $______ (the “Option Price”) subject to adjustment as provided in Paragraph 8 hereof.

     3.    Vesting of Option. [SELECT WHICH VESTING OPTION APPLIES] [This option shall vest as to 20% of the shares covered hereby on the one year anniversary of the date of Grant. Thereafter, this Option shall vest as to an additional 20% of the shares covered hereby, cumulatively, on the second, third, fourth and fifth anniversary dates of the Date of Grant.] OR [This option shall be immediately fully vested from the Date of Grant]. Vesting shall occur only while the recipient is an employee, officer or director of or consultant to the Corporation.

     4.    Exercise of Option. Except as otherwise provided in the Plan and Paragraph 3 above, this Option may be exercised in whole or in part at any time during the term of the Option, provided, however, no portion of this Option shall be exercisable (i) after the expiration of the term thereof, and (ii) unless the holder shall at the time of exercise have been an employee, officer or director of or a consultant to the corporation for a period of at least six months.

-1-

     The Option may be exercised, as provided in this Paragraph 4, by notice and payment to the Corporation as provided in Paragraph 9 hereof and Section 6 of the Plan.

     5.    Term of Option. The term of the Option will be through ____________, 20___, subject to earlier termination or cancellation as provided in this Stock Option Grant and the Plan.

     The holder of the Option will not have any rights to dividends or any other rights of a shareholder with respect to any shares of Common Stock subject to the Option until such shares shall have been purchased through the exercise of the Option and has been evidenced on the stock transfer records of the Corporation maintained by the Corporation’s transfer agent.

     6.    Transferability Restriction. The Option may not be assigned, transferred or otherwise disposed of, or pledged or hypothecated in any way (whether by operation of law or otherwise) except in strict compliance with Section 6 of the Plan. Any assignment, transfer, pledge, hypothecation or other disposition of the Option or any attempt to make any such levy of execution, attachment or other process will cause the Option to terminate immediately upon the happening of any such event, provided, however, that any such termination of the Option under the foregoing provisions of this Paragraph 6, will not prejudice any rights or remedies which the Corporation may have under this Stock Option Grant or otherwise.

     7.    Death, Disability or Retirement of Recipient. The Recipient’s rights to exercise this Option upon the death, Disability or retirement of the Recipient shall be as set forth in Section 6 of the Plan.

     8.    Adjustments. The Option shall be subject to adjustment upon the occurrence of certain events as set forth in Section 6 of the Plan.

     9.    Notices. Each notice relating to this Stock Option Grant will be in writing and delivered in person or by certified mail to the proper address. Notices to the Corporation shall be addressed to the Corporation c/o Michael I. Ruxin, M.D., Chairman of the Board of Directors and CEO, at 12600 W. Colfax, Suite C-420, Lakewood, Colorado 80215. Notices to the Recipient or other person or persons then entitled to exercise the Option shall be addressed to the Recipient or such other person or persons at the Recipient’s address specified below. Anyone to whom a notice may be given under this Stock Option Grant may designate a new address by notice to that effect given pursuant to this Paragraph 9.

     10.    Approval of Consent. The exercise of the Option and the issuance and delivery of shares of Common Stock pursuant thereto shall be subject to approval by the Corporation’s counsel of all legal matters in connection therewith, including compliance with the requirements of the Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, applicable state securities laws, the rules and regulations there under, and the requirements of any national securities exchange or association upon which the Common Stock then may be listed.

-2-

     11.    Benefits of Stock Option Grant. This Stock Option Grant will inure to the benefit of and be binding upon each successor and assign of the Corporation. All obligations imposed upon the Recipient and all rights granted to the Corporation under this Stock Option Grant will be binding upon the Recipient’s heirs, legal representatives and successors.

     12.    Governmental and Other Regulations. The exercise of the Option and the Corporation’s obligation to sell and deliver shares upon the exercise of rights to purchase shares is subject to all applicable federal and state laws, rules and regulations, and to such approvals by any regulatory or governmental agency which, in the opinion of counsel for the Corporation, may be required.

     13.    Conflicts with the Plan. If any provision in this Stock Option Grant materially conflicts with a provision in the Plan, the Plan shall govern.

     Executed in the name and on behalf of the Corporation by one of its duly authorized officers and by the Recipient all as of the date first above written.

GLOBAL MED TECHNOLOGIES, INC.


By______________________________
    Michael I. Ruxin, M.D., Chairman of the Board
    and Chief Executive Officer

     The undersigned Recipient understands the terms of this Stock Option Grant. The undersigned acknowledges that he or she can receive a copy of the Plan by request to the Corporation. The undersigned agrees to comply with the terms and conditions of the Plan.

Date _______________, _____

_____________________________________
(Signature)
Name: _______________________________
Tax ID Number:________________________
Address: ____________________________
______________________________________
______________________________________

-3-

Exhibit B

FORM OF
SUBSCRIPTION AGREEMENT

      THE SECURITIES OF GLOBAL MED TECHNOLOGIES, INC. BEING SUBSCRIBED FOR HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AND ARE “RESTRICTED SECURITIES” AS THAT TERM IS DEFINED IN RULE 144 UNDER THE ACT. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD OR OTHERWISE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT, OR PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE ACT, THE AVAILABILITY OF WHICH IS TO BE ESTABLISHED TO THE SATISFACTION OF THE COMPANY.

     IN MAKING AN INVESTMENT DECISION INVESTORS MUST RELY ON THEIR OWN EXAMINATION OF THE PERSON OR ENTITY CREATING THE SECURITIES AND THE TERMS OF THE OFFERING, INCLUDING THE MERITS AND RISKS INVOLVED. THESE SECURITIES HAVE NOT BEEN RECOMMENDED BY ANY FEDERAL OR STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY. FURTHERMORE, THE FOREGOING AUTHORITIES HAVE NOT CONFIRMED THE ACCURACY OR DETERMINED THE ADEQUACY OR DETERMINED THE ADEQUACY OF THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

     THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY WILL BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME.

     This Subscription Agreement is entered for the purpose of the Undersigned acquiring _____________ shares of the $.01 par value common stock (the “Securities”) of GLOBAL MED TECHNOLOGIES, INC., a Colorado corporation (the “Corporation”), from the Corporation upon the exercise of an Option pursuant to the Corporation’s 2003 Stock Option Plan (the “Plan”). It is understood that exercise of an Option at a time when no registration statement relating thereto is effective under the Securities Act of 1933, as amended (the “Securities Act”), can not be completed until the Undersigned executes this Subscription Agreement and delivers it to the Corporation, and then such exercise is effective only upon acceptance of this Subscription Agreement by the Corporation, and in accordance with the terms of the Plan and this Subscription Agreement.

-1-

     In connection with the Undersigned’s acquisition of the Securities, the Undersigned represents and warrants to the Corporation as follows:

     1.    The Undersigned has reviewed all available reports filed by the Corporation pursuant to the Securities Exchange Act of 1934, including (without limitation) the Corporation’s most recent annual report on Form 10-K for the most recently-completed fiscal year and all Forms 10-Q for the quarters subsequent to the end of the most recent fiscal year, the Plan, and such other information as the Undersigned may have requested of the Corporation regarding its business, operations, management, and financial condition (all of which is referred to herein as the “Available Information”).

     2.    The Corporation has given the Undersigned the opportunity to ask questions of and to receive answers from persons acting on the Corporation’s behalf concerning the terms and conditions of this transaction and the opportunity to obtain any additional information regarding the Corporation, its business and financial condition which the Corporation possesses or can acquire without unreasonable effort or expense.

     3.    The Securities are being acquired by the Undersigned for his own account and not on behalf of any other person or entity. The Undersigned’s present financial condition is such that it is unlikely that it would be necessary for the Undersigned to dispose of any portion of the Securities in the foreseeable future.

     4.    The Undersigned understands that the Securities being acquired hereby have not been registered under the Securities Act or any state or foreign securities laws, and are and will continue to be restricted securities within the meaning of Rule 144 of the General Rules and Regulations under the Securities Act and applicable state statutes, and consents to the placement of an appropriate restrictive legend or legends on any certificates evidencing the Securities and any certificates issued in replacement or exchange therefor and acknowledges that the Corporation will cause its stock transfer records to note such restrictions.

     5.    By the Undersigned’s execution below, it is acknowledged and understood that the Corporation is relying upon the accuracy and completeness hereof in complying with certain obligations under applicable securities laws.

     6.    This Agreement binds and inures to the benefit of the representatives, successors and permitted assigns of the respective parties hereto.

-2-

     7. The Undersigned acknowledges and agrees that the Corporation may withhold shares of Common Stock issuable upon the exercise of the Option for the payment of taxes as a result of the exercise of the Option in satisfaction of federal withholding taxes.

(Undersigned)

__________________, ___

_____________________________________
(Signature)
Name: _______________________________
Tax ID Number:________________________
Address: ____________________________
______________________________________
______________________________________

ACCEPTANCE

     This Subscription Agreement is hereby accepted as of the _____ day of ____________, 20__.

GLOBAL MED TECHNOLOGIES, INC.


By______________________________
    Michael I. Ruxin, M.D., Chairman of the Board
    and Chief Executive Officer

-3-

EX-23

EXHIBIT 23.1

INDEPENDENT AUDITORS’ CONSENT

Board of Directors
Global Med Technologies, Inc. and subsidiary:

We consent to the incorporation by reference in this Registration Statement of Global Med Technologies, Inc. on Form S-8 of our report dated February 6, 2004, except for Notes 2 and 11, as to which are dated April 14, 2004, appearing in the Annual Report on Form 10-K of Global Med Technologies, Inc. for the year ended December 31, 2003.

/s/ Ehrhardt Keefe Steiner & Hottman PC
Ehrhardt Keefe Steiner & Hottman PC

Denver, Colorado
May 20, 2004